Dr. Roy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4975 Bradenton Ave
Dublin, OH 43017Phone+1 614-766-0773Fax+1 614-766-2599
Education & Training
- Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2005 - 2006
- OhioHealth/Riverside Methodist HospitalInternship, Internal Medicine, 2001 - 2002
- Northeast Ohio Medical UniversityClass of 2001
Certifications & Licensure
- KY State Medical License 2024 - 2026
- OH State Medical License 2001 - 2026
- WV State Medical License 2024 - 2025
- PA State Medical License 2008 - 2012
- MA State Medical License 2006 - 2009
- DC State Medical License 2003 - 2006
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013
Clinical Trials
- Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea Start of enrollment: 2019 Sep 23
Publications & Presentations
PubMed
- Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of...Wayne Macfadden, Eileen B Leary, Douglas S Fuller, M Todd Kirby, Asim Roy
Journal of Clinical Sleep Medicine. 2024-09-01 - Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations.Anne Marie Morse, Richard K Bogan, Asim Roy, Michael J Thorpy
Neurology and Therapy. 2024-06-01 - 1 citationsCost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory Analysis.Anne M Ryschon, Khoa N Cao, Asim Roy, Jan B Pietzsch
Neurology and Therapy. 2023-12-01
Press Mentions
- Narcolepsy Medication Lumryz Linked to Weight LossAugust 20th, 2024
- ZOLL Remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional UseMay 25th, 2023
- ZOLL Remedē System Receives FDA Approval for Sleep Apnoea TreatmentMay 25th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: